Global Health Q2 Results FY27: PAT Rises 38.35% to Rs 219.14 Cr, Revenue Rs 1,469.04 Cr

Global Health Ltd (MEDANTA) Q2 Results FY27 announced on 3 November 2026, covering the company's financial performance for the July to September quarter. Under Global Health Q2 Results FY27, the company posted Consolidated revenue of Rs 1,469.04 Cr and a net profit of Rs 219.14 Cr. The results date of 3 November 2026 puts these consolidated results in the public domain on NSE and BSE.

This Global Health Q2 Results results analysis looks at how revenue, Operating Profit and net profit moved against the same quarter a year ago. It then covers the business factors, the FY27 outlook and the risks, and the Univest Screener tracks the same MEDANTA figures. The Financial Highlights section comes first.

Click Here – Get Free Investment Predictions

Global Health Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 1469.04 Cr	Rs 1099.22 Cr	+33.64% YoY
Operating Profit	Rs 370.09 Cr	Rs 230.94 Cr	+60.25% YoY
Net Profit (PAT)	Rs 219.14 Cr	Rs 158.4 Cr	+38.35% YoY

Source: company filing for Global Health Q2 Results FY27, 3 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Global Health Q2 Results: What Stands Out

• Revenue reached Rs 1,469.04 Cr, compared with Rs 1,099.22 Cr a year earlier, which is a rise of 33.64% on a Consolidated basis.
• Operating Profit climbed 60.25% to Rs 370.09 Cr from Rs 230.94 Cr, growing much faster than revenue over the same period.
• Net profit of Rs 219.14 Cr against Rs 158.40 Cr gives YoY growth of 38.35%, so the bottom line grew more slowly than Operating Profit.
• Revenue has risen in each of the last 4 quarters, which places Global Health Q2 Results FY27 inside a run of consecutive sequential gains.
• The performance analysis that follows sets out how the three profit and revenue lines relate to each other.

Global Health Q2 Results FY27: Performance Analysis

Global Health ended the July to September 2026 quarter with Consolidated revenue of Rs 1,469.04 Cr, 33.64% higher than Rs 1,099.22 Cr a year earlier. Operating Profit and net profit also grew, at 60.25% and 38.35% respectively, so all three lines moved in the same direction.

The results analysis shows an unusual spread between the profit lines. Operating Profit rose from Rs 230.94 Cr to Rs 370.09 Cr, while net profit moved from Rs 158.40 Cr to Rs 219.14 Cr. In Global Health Q2 Results FY27, the Rs 370.09 Cr Operating Profit is the line that grew fastest, ahead of revenue growth of 33.64%.

Net profit growth of 38.35% is still above the revenue growth rate of 33.64%, so YoY growth at the bottom line outpaced the top line even after the slower pace relative to Operating Profit. Investors following Global Health Q2 Results will focus on whether these Consolidated growth rates carry into later quarterly results, which brings the analysis to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Expansion – The quarterly results begin with revenue, which grew 33.6% year on year to Rs 1,469.04 Cr in the latest quarter. This expansion is the starting point for every other line in Global Health Q2 Results FY27, since Operating Profit and net profit are both measured against it.

Net Profit Growth – Net profit rose 38.3% year on year to Rs 219.14 Cr. The company converted the higher revenue base into a larger profit, so the Consolidated bottom line grew alongside the top line instead of lagging behind it.

Consistent Sequential Revenue and Return on Equity – Revenue has risen in each of the last 4 quarters, and return on equity was 15.12% in FY26. Together these show a business with a steady revenue run and a double-digit return on shareholder capital.

FY27 Outlook After Global Health Q2 Results

This FY27 outlook is drawn from the reported numbers alone. Revenue of Rs 1,469.04 Cr and net profit of Rs 219.14 Cr set the quarterly base, and full-year FY27 results will depend on what the next quarters add, a point that matters for anyone using this results analysis to track the year.

Full-year FY27 results will also reflect disclosed sector conditions as they emerge. With revenue rising for 4 straight quarters, the next net profit prints will show whether the Rs 219.14 Cr level holds, and that question connects to the risks that investors should weigh next.

Key Risks to Watch After Global Health Q2 Results FY27

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 95.02 Cr to Rs 219.14 Cr over the last 5 quarters. After Global Health Q2 Results FY27, the latest figure sits at the top of that range, so sustaining it will be the test.

Declining Return on Capital Employed

Return on capital employed declined to 19.38% in FY26 from 20.50% in FY25. The YoY growth in the latest quarter has to be read alongside this softer capital return from the prior full year.

Debt Position

Debt was 0.16 times total assets in FY26. That is a low ratio, but investors tracking the quarterly results should still check how borrowings move in later disclosures as the company continues to grow.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Global Health Q2 Results FY27 deliver Consolidated revenue of Rs 1,469.04 Cr, Operating Profit of Rs 370.09 Cr and net profit of Rs 219.14 Cr, all higher YoY. The quarterly results reflect broad growth across the three lines, while the risks above stay relevant for later quarters. Investors should consult a SEBI-registered advisor before acting on this Global Health Q2 Results summary.

Frequently Asked Questions on Global Health Q2 Results FY27

What are Global Health Q2 Results FY27?

Ans. Global Health Q2 Results FY27 are the second quarter results of FY27 for Global Health, covering July to September 2026, with Consolidated revenue of Rs 1,469.04 Cr and net profit of Rs 219.14 Cr, as the Quick Answer summarises.

What is the results date for Global Health Q2 Results FY27?

Ans. The results date for Global Health Q2 Results FY27 is 3 November 2026, when Global Health declared its July to September numbers, and this is the filing date behind the Financial Highlights table in this article.

What revenue was reported in Global Health Q2 Results FY27?

Ans. Global Health Q2 Results FY27 report revenue of Rs 1,469.04 Cr, compared with Rs 1,099.22 Cr a year earlier, so the Financial Highlights table shows YoY growth of 33.64% on a Consolidated basis.

What net profit was reported in Global Health Q2 Results FY27?

Ans. Global Health reported net profit of Rs 219.14 Cr in Global Health Q2 Results FY27, up from Rs 158.40 Cr a year earlier, which is the 38.35% YoY growth explained in the Key Takeaways section.

How much YoY growth did revenue show in Global Health Q2 Results FY27?

Ans. Revenue showed YoY growth of 33.64% in Global Health Q2 Results FY27, rising from Rs 1,099.22 Cr to Rs 1,469.04 Cr, while the Performance Analysis section compares it with faster Operating Profit growth.

Did net profit rise or fall in Global Health Q2 Results?

Ans. Net profit rose in Global Health Q2 Results, moving from Rs 158.40 Cr to Rs 219.14 Cr, a gain of 38.35%, which means it grew faster than revenue, as the Performance Analysis explains.

What was the Operating Profit in Global Health Q2 Results FY27?

Ans. Operating Profit in Global Health Q2 Results FY27 was Rs 370.09 Cr, up 60.25% from Rs 230.94 Cr a year earlier, which makes it the fastest growing line, as discussed in the Performance Analysis section.

Are Global Health Q2 Results consolidated results or standalone results?

Ans. Global Health Q2 Results are Consolidated results, with revenue of Rs 1,469.04 Cr and net profit of Rs 219.14 Cr, so every comparison in the Financial Highlights table is on a Consolidated basis.

What business factors shaped Global Health Q2 Results FY27?

Ans. Revenue growth of 33.6%, net profit growth of 38.3%, four straight quarters of rising revenue and return on equity of 15.12% shaped Global Health Q2 Results FY27, as the Key Business Factors section details.

What are the key risks after Global Health Q2 Results FY27?

Ans. The risks after Global Health Q2 Results FY27 include net profit volatility, a lower return on capital employed of 19.38% and debt at 0.16 times total assets, all covered in the Key Risks section.

What is the outlook after Global Health Q2 Results?

Ans. The outlook after Global Health Q2 Results depends on later quarters, because FY27 full-year results will build on Rs 1,469.04 Cr of quarterly revenue and Rs 219.14 Cr of profit, per the Outlook section.

Where can I find the complete Global Health Q2 Results FY27 data?

Ans. The complete Global Health Q2 Results FY27 data is in the Financial Highlights table above, while the Univest Screener and the Univest app help readers follow MEDANTA through later quarterly results.